MedTrace Logo

Brain STimulation for ANxiety and Depression in Youth

NCT06892847 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2026-01-29

No results posted yet for this study

Summary

In this open-label trial, the overall aim is to determine if TMS treatment can improve anxiety and depression in a broad group of children and youth referred by physicians.

Conditions

Interventions

PROCEDURE

Transcranial Magnetic Stimulation

Participants will receive TMS for treatment measures as determined by referral and presentation.

Sponsors & Collaborators

  • University of Calgary

    lead OTHER

Principal Investigators

  • Kara Murias, MD/PhD · The University of Calgary

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
6 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-07-01
Primary Completion
2028-12-31
Completion
2028-12-31

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06892847 on ClinicalTrials.gov